TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Priya M. Mathews, MD, MPH, explains why she offers Vevye for the treatment of dry eye disease.
According to Mathews, Vevye (cyclosporine ophthalmic solution 0.1%, Harrow) addresses two important factors of dry eye treatment: bioavailability and patient tolerability.
“I’ve been very impressed with the results, which are in line with what the studies have shown as well,” she said.